(Total Views: 1245)
Posted On: 05/25/2017 9:28:21 AM
Post# of 3
$AVGR Hold for VISION study for the Company’s Lumivascular technology, New Cardiovascular Horizons (NCVH) annual conference on May 31, 2017
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569
http://investors.avinger.com/phoenix.zhtml?c=...ID=2276569
(0)
(0)Scroll down for more posts ▼
